EMA Custom Webtools Rating widget: Hidden by field_ema_hide_rating for this node.
Cancer
This page brings together the European Medicines Agency's (EMA) latest information on cancer.
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
It lists the following:
- The newest and recently updated medicines authorised for cancer in the European Union
- EMA's latest cancer-related news announcements
- EMA's upcoming events on cancer-related topics
We are currently unable to display the new and recently updated medicines authorised for cancer due to a technical error. We are working to resolve the issue as soon as possible. We apologise for any inconvenience caused.
Latest news
Two new medicines recommended for approval; another eight medicines recommended for extension of their therapeutic indications
17 oktober 2025
14 new medicines recommended for approval; another six medicines recommended for extension of their therapeutic indications
19 september 2025
13 new medicines recommended for approval; another 8 medicines recommended for extension of their therapeutic indications
25 juli 2025
Zemcelpro provides an option for patients with blood cancer who need a blood stem cell transplant and have no suitable donor
20 juni 2025
Events of interest
Currently, we have no events for this therapeutic area.